| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/07/1990 | CN1040222A Process for preparing de-b30-insulins and de-b30-insulins derivs. |
| 03/07/1990 | CN1040221A Procalcitonin peptides |
| 03/07/1990 | CN1040205A Cytotoxic drug conjugates |
| 03/07/1990 | CN1040204A Cytotoxic drug conjugates |
| 03/06/1990 | US4906734 Human conglutinin |
| 03/06/1990 | US4906562 Monocolonal antibodies and antigen for human non-small cell lung carcinomas |
| 03/06/1990 | US4906468 Insulin activity messengers, their antibodies, and thereof |
| 03/06/1990 | US4906452 Trichothecene conjugates and methods of use |
| 03/01/1990 | DE3828582A1 Monoklonaler antikoerper zur inhibierung der infektion von zellen durch hiv-viren A monoclonal antibody to inhibit the infection of cells by HIV viruses |
| 02/28/1990 | EP0356409A2 A method for the production and isolation of a fusion protein in eukaryotic cells |
| 02/28/1990 | EP0356397A2 Monoclonal antibodies against, and cell surface antigen of, lung carcinoma |
| 02/28/1990 | EP0356395A2 Flanking peptides and process for their preparation |
| 02/28/1990 | EP0356335A1 Signal peptide and DNA sequences coding thereof |
| 02/28/1990 | EP0355811A2 Thrombus control agent |
| 02/28/1990 | EP0355779A2 Isolation, purification, and characterization of the methionine-specific aminopeptidases: MAS I and MAS X |
| 02/28/1990 | EP0355737A2 Expression of functional homologous and heterologous proteins on the outer membrane of E.coli and other gram-negative bacteria |
| 02/28/1990 | EP0355720A1 Process for the preparation of motilin-like polypeptide and expression thereof |
| 02/28/1990 | EP0355460A2 Stabilization of somatotropins by modification of cysteine residues utilizing site directed mutagenesis or chemical derivatization |
| 02/28/1990 | EP0355142A1 Site-specific homogeneous modification of polypeptides to facilitate covalent linkages to a hydrophilic moiety |
| 02/28/1990 | EP0355140A1 Human monoclonal anti-hiv-i-antibodies |
| 02/28/1990 | EP0355093A1 Human interleukin-3 and muteins thereof |
| 02/28/1990 | EP0143850B1 Novel physiologically active proteinaceous substance |
| 02/28/1990 | CN1040054A Compound having biological activity, and preparing process therefor |
| 02/28/1990 | CN1040053A Expression of hepatitis b pres2 protein in methylotrophic yeasts |
| 02/28/1990 | CN1040052A Kluyveromyces as host strain |
| 02/27/1990 | US4904763 Physiologically-active novel peptides |
| 02/27/1990 | US4904596 Medical diagnosis |
| 02/27/1990 | US4904584 Erythropoietin or a colony stimulating factor having lysine replacements and at least one polyoxyalkylene glycol moiety; solubility; pharmacokinetics |
| 02/27/1990 | CA1266234A1 Method of binding microflora |
| 02/27/1990 | CA1266233A2 Monoclonal antibody to candida albicans cytoplasmic antigens and methods of preparing same |
| 02/22/1990 | WO1990001555A1 A process for enzymatic production of dipeptides or structurally related compounds |
| 02/22/1990 | WO1990001551A1 Producing commercially valuable polypeptides with genetically transformed endosperm tissue |
| 02/22/1990 | WO1990001550A1 High efficiency translation of polycistronic messages in eucaryotic cells |
| 02/22/1990 | WO1990001540A1 Method for stabilizing heterologous protein expression and vectors for use therein |
| 02/22/1990 | WO1990001498A1 Process for purification of islet cells; monoclonal antibodies directed to islet and acinar cells; and process for making and using same |
| 02/22/1990 | WO1990001496A1 Polypeptides and dna encoding same |
| 02/22/1990 | WO1990001339A1 Detection and treatment of infectious and inflammatory lesions |
| 02/22/1990 | WO1990001338A1 Leukocyte adhesion inhibitor |
| 02/22/1990 | WO1990001336A1 Novel infectious bursal disease virus |
| 02/22/1990 | WO1988007551A3 Growth factor receptor |
| 02/21/1990 | EP0355047A1 Purified protein A compositions and methods for their preparation |
| 02/21/1990 | EP0355039A2 Methods and means for controlling the stability of proteins |
| 02/21/1990 | EP0354934A1 Neutrophil-activating polypeptide, process for its manufacture and its use as a drug and diagnosticum |
| 02/21/1990 | CN1039843A Process for producing hegf |
| 02/21/1990 | CN1006903B Production method for interleukin-2 |
| 02/20/1990 | US4902783 Adsorption with silica gel, adsorption with activated carbon, density gradient centrifuging and equilibrium density gradient centrifuging |
| 02/20/1990 | US4902618 Production of hybridoma antibodies for interferon |
| 02/20/1990 | US4902615 Diagnostic kit for cancer |
| 02/14/1990 | EP0354729A2 Cytotoxic drug conjugates |
| 02/14/1990 | EP0354728A2 Cytotoxic drug conjugates |
| 02/14/1990 | EP0354592A1 A novel human physiologically active polypeptide |
| 02/14/1990 | EP0354580A2 HLA class I DNA, DNA probes and transformed cells |
| 02/14/1990 | EP0354507A2 Process for producing des-B30 insulins and derivatives thereof |
| 02/14/1990 | EP0354504A2 Hybrid protein C constructs and methods for their preparation |
| 02/14/1990 | EP0354440A1 Human Papilloma virus type 57, its DNA and proteins encoded thereby |
| 02/14/1990 | EP0354408A1 Anti-urokinase monoclonal antibodies |
| 02/14/1990 | EP0354354A2 Process for concentrating blood coagulation factors II, VII, IX en X |
| 02/14/1990 | CN1006808B Purification of lipotropic protein produced by pichia yeast |
| 02/13/1990 | US4900673 Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression |
| 02/13/1990 | US4900661 Method for immunological determination of amines, monoclonal antibodies and kit of reagents for carrying out the method |
| 02/08/1990 | WO1990001066A1 Porcine polyclonal and monoclonal antibodies |
| 02/08/1990 | WO1990001063A1 New secretory leader sequences |
| 02/08/1990 | WO1990001039A1 Nonglycosylated human interleukin-3 compositions |
| 02/08/1990 | WO1990001038A1 Human insulin analogs and preparations containing them |
| 02/08/1990 | WO1990000902A1 Monoclonal antibodies reactive with cachectin |
| 02/08/1990 | WO1990000601A3 Novel glucose isomerase enzymes and their use |
| 02/08/1990 | WO1989009788A3 Biosynthetic osteogenic proteins and osteogenic devices containing them |
| 02/08/1990 | WO1989009787A3 Osteogenic devices |
| 02/07/1990 | EP0354100A1 Process for the treatment and decoloration of protein solutions containing pigments from the groups haemo and chlorophyl, and products obtained |
| 02/07/1990 | EP0354072A1 Precursors of the HIV-2 retrovirus envelope glycoprotein and related antigens |
| 02/07/1990 | EP0353960A2 Polyspecific anti-leukocyte conjugate for detection and treatment of infectious and inflammatory lesions |
| 02/07/1990 | EP0353910A2 Human interferon-gamma, process for preparing said human interferon-gamma, and its use |
| 02/07/1990 | EP0353814A2 Synthetic peptide endowed with immunological activity, capable of inducing the production of antibodies with a high specificity towards alpha-fetoprotein, and their use in the diagnostic field |
| 02/07/1990 | EP0353809A1 Pseudorabies virus vaccine |
| 02/07/1990 | EP0353516A2 A method for the preparation of recombinant human beta interleukin-1 in the homogeneous form |
| 02/07/1990 | EP0353250A1 The engineering of electrostatic interactions at metal ion binding sites for the stabilization of proteins |
| 02/07/1990 | CN1039441A Viper venom polypeptides and genetic expression |
| 02/06/1990 | US4898931 Novel human interferon-γ polypeptide derivative |
| 02/06/1990 | US4898930 Peptide derivatives and processes for their preparation |
| 02/06/1990 | CA1265650A1 Method for purifying a physiologically active substance produced by recombinant dna technique |
| 02/06/1990 | CA1265648A1 Leukemia-associated virus immunogen, vaccine and assay |
| 02/06/1990 | CA1265447A1 Hepatitis b antigenic compositions and vaccines against hepatitis b derived therefrom |
| 02/05/1990 | EP0272253A4 Method for enhancing glycoprotein stability. |
| 01/31/1990 | EP0353150A1 Recombinant non-glycosylated human IL2 in reduced form, process for its production and its medical use |
| 01/31/1990 | EP0353111A1 Nucleic acid or fragments thereof encoding the P30 protein of Toxoplasma gondii, methods for their preparation and uses thereof |
| 01/31/1990 | EP0352839A2 Process for producing hEGF |
| 01/31/1990 | EP0352784A2 Gamma-glutamyl cystein transferase, process for its production and use of same |
| 01/31/1990 | EP0352761A2 Antigens composed of "major histocompatibility complex" class I antigens and specific carrier molecules, their production and use |
| 01/31/1990 | EP0352707A2 An expression system for the secretion of bioactive human granulocyte macrophage colony stimulating factor (GM-CSF) and other heterologous proteins from streptomyces |
| 01/31/1990 | EP0352678A2 Method for separating and recovering proteins present in fluids by means of a rotary column |
| 01/31/1990 | EP0352651A1 Human protein C mutants and method for preparing the same |
| 01/31/1990 | EP0352646A2 FR901228 Substance and preparation thereof |
| 01/31/1990 | EP0352538A2 Amides of N15-alkyl and N15,N15-dialkyl teicoplanin derivatives |
| 01/31/1990 | EP0352387A1 Method for preparing a hirudin |
| 01/31/1990 | EP0352328A1 Human monoclonal antibody against aspergilli |
| 01/30/1990 | US4897471 Consensus human leukocyte interferon |
| 01/30/1990 | US4897354 Monoclonal antibody-specific merozoite antigens |
| 01/30/1990 | US4897264 Human gamma interferon-specific receptor protein, antibody against said protein, methods for obtaining said protein and said antibody and compositions containing said protein and antibody |
| 01/30/1990 | CA1265050A1 Purification of blood clotting factors and other blood proteins on non-carbohydrate sulfated matrices |
| 01/26/1990 | EP0362298A4 Novel polypeptide having gamma-interferon activity. |